Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-03-05
1985-04-09
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548510, 548511, C07D20918, A61K 3140
Patent
active
045101582
ABSTRACT:
4-(1-R'-2-phenyl-1H-indol-3-yl)-3-cyclohexene-1-carboxylic acids, 4-(1'R'-2-phenyl-1H-indol-3-yl)cyclohexane-1-carboxylic acids, 4-(1-R'-2-phenyl-1H-indol-3-yl)benzoic acids, the corresponding cyclohexene- and cyclohexane-1,1-dicarboxylic acids, and lower-alkyl esters thereof, wherein R' is hydrogen or lower-alkyl, are prepared by reacting a 1-R'-2-phenyl-1H-indole with a cyclohexanone-4-carboxylic acid or -4,4-dicarboxylic acid, followed as desired by a hydrogenation or aromatization process. The compounds which are free carboxylic acids or salts thereof are useful as complement inhibitors. The corresponding esters are useful as intermediates.
REFERENCES:
patent: 3551451 (1970-12-01), Szmuszkovicz
Patrick, R. A. & Johnson, R. E., Annual Reports in Medicinal Chemistry, vol. 15, Academic Press, New York, NY, 1980; Chapter 20, pp. 193-201.
Freter, K., J. Org. Chem., vol. 40, 2525-2529 (1975).
Daus Donald G.
DuPont Paul E.
Hendricks G.
Johnson Thomas L.
Sterling Drug Inc.
LandOfFree
2-Phenylindole derivatives, their use as complement inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-Phenylindole derivatives, their use as complement inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Phenylindole derivatives, their use as complement inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1169367